-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Antibe Therapeutics Inc. (TSE:ATE) Director John Lawrence Wallace Sells 21,500 Shares
Antibe Therapeutics Inc. (TSE:ATE) Director John Lawrence Wallace Sells 21,500 Shares
Antibe Therapeutics Inc. (TSE:ATE – Get Rating) Director John Lawrence Wallace sold 21,500 shares of Antibe Therapeutics stock in a transaction on Thursday, July 7th. The stock was sold at an average price of C$0.62, for a total transaction of C$13,330.00. Following the sale, the director now directly owns 1,899,576 shares of the company's stock, valued at C$1,177,737.12.
TSE ATE opened at C$0.62 on Wednesday. Antibe Therapeutics Inc. has a 52-week low of C$0.59 and a 52-week high of C$3.65. The company has a debt-to-equity ratio of 0.29, a quick ratio of 11.92 and a current ratio of 13.07. The company has a market capitalization of C$31.86 million and a P/E ratio of -1.16. The company has a fifty day moving average of C$0.66 and a 200-day moving average of C$0.70.
Get Antibe Therapeutics alerts:Antibe Therapeutics Company Profile (Get Rating)
Antibe Therapeutics Inc, a biotechnology company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs.Read More
- Should These Two Airlines Be In Your Portfolio?
- Old Dominion Freight Line (ODFL): This Dividend Growth Stock Deserves Your Attention
- Is There a Reasonable Price to Buy Stitch Fix Stock?
- 3 Smid Caps Under $20 Set to Recover
- Continuining to Assess Tesla's Future As The EV Market Becomes Increasingly Competitive
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
Antibe Therapeutics Inc. (TSE:ATE – Get Rating) Director John Lawrence Wallace sold 21,500 shares of Antibe Therapeutics stock in a transaction on Thursday, July 7th. The stock was sold at an average price of C$0.62, for a total transaction of C$13,330.00. Following the sale, the director now directly owns 1,899,576 shares of the company's stock, valued at C$1,177,737.12.
安提贝治疗公司(多伦多证券交易所代码:ATE-GET评级)董事约翰·劳伦斯·华莱士在7月7日星期四的一笔交易中出售了21,500股安提伯治疗公司的股票。该股以0.62加元的平均价格出售,总成交金额为13,330.00加元。交易完成后,董事现在直接持有该公司1,899,576股股票,价值1,177,737.12加元。
TSE ATE opened at C$0.62 on Wednesday. Antibe Therapeutics Inc. has a 52-week low of C$0.59 and a 52-week high of C$3.65. The company has a debt-to-equity ratio of 0.29, a quick ratio of 11.92 and a current ratio of 13.07. The company has a market capitalization of C$31.86 million and a P/E ratio of -1.16. The company has a fifty day moving average of C$0.66 and a 200-day moving average of C$0.70.
周三,Tse ATE开盘报0.62加元。安提贝治疗公司的股价跌至0.59加元的52周低点和3.65加元的52周高点。该公司的负债权益比率为0.29,速动比率为11.92,流动比率为13.07。该公司市值为3,186万加元,市盈率为-1.16。该公司的50日移动均线切入位在0.66加元,200日移动均线切入位在0.70加元。
Antibe Therapeutics Company Profile (Get Rating)
安提贝治疗公司简介(获取评级)
Read More
阅读更多内容
- Should These Two Airlines Be In Your Portfolio?
- Old Dominion Freight Line (ODFL): This Dividend Growth Stock Deserves Your Attention
- Is There a Reasonable Price to Buy Stitch Fix Stock?
- 3 Smid Caps Under $20 Set to Recover
- Continuining to Assess Tesla's Future As The EV Market Becomes Increasingly Competitive
- 这两家航空公司应该在你的投资组合中吗?
- Old Dominion Freight Line(ODFL):这只红利成长股值得你关注
- 是否有一个合理的价格购买缝纫机修理股票?
- 3个20美元以下的SmidCaps将回升
- 随着电动汽车市场竞争日益激烈,继续评估特斯拉的未来
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受《安提贝治疗日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对安替比治疗公司和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧